Healthcare Analyst Tsai, along with Dr. Conrad Nievera, discuss rare muscle diseases, (relevant companies SRPT DYN RNA PEPG CAPR) on an Analyst/Industry conference call to be held on December 18 at 1:45 pm. Webcast Link
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNA:
- 3 Best Stocks to Buy Now, 12/13/2024, According to Top Analysts
- Avidity Biosciences initiated with an Outperform at RBC Capital
- Dyne Therapeutics initiated with an Outperform at RBC Capital
- Biotech Alert: Searches spiking for these stocks today
- 3 Best Stocks to Buy Now, 11/13/2024, According to Top Analysts